Von Willebrand factor in plasma of patients with advanced stages of larynx cancer

Thrombosis Research

Volumn 95, Issue 4, 1999, Pages 197-200

  Paczuski, Ryszard ^a   Bialkowska, Aneta ^a   Kotschy, Maria ^a   Burduk, Danuta ^a   Betlejewski, Stanislaw ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Larynx cancer; von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LARYNX CANCER; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; CASE-CONTROL STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; VON WILLEBRAND FACTOR;

EID: 0032881002     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00041-9     Document Type: Article

References (19)

1. Jaffe E.A., Hoyer L.W., Nachman R.L. Synthesis of antihemophilic factor antigen by human endothelial cells. J Clin Invest. 52:1973;2757-2764.
2. Jaffe E.A., Hoyer L.W., Nachman R.L. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA. 71:1974;1906-1909.
3. Belch J.J.F., Zoma A.A., Richards I.M., Mclaughlin K., Forbes C.D., Sturrock R.D. Vascular damage and factor VIII related antigen in the rheumatic diseases. Rheumatol Int. 7:1987;107-111.
4. Gordon J.L., Pottinger B.E., Woo P., Rosenbaum J., Black C.M. Plasma von Willebrand factor in connective tissue disease. Ann Rheum Dis. 40:1987;491-492.
5. Greaves M., Pickering C., Knight G., Boulton A.J.M., Ball J., Ward J.D., Preston F.E. Changes in the factor VIII complex in diabetic ketoacidosis. evidence of endothelial cell damage? Diabetologia. 30:1987;160-165.
6. Blann A.D. Von Willebrand factor as an acute phase reactant and marker of endothelial cell injury in connective tissue diseases. A comparison with CRP, rheumatoid factor, and erythrocyte sedimentation rate Zeitschrift für Rheumatologie. 50:1991;320-322.
7. Pottinger B.E., Read R.C., Paleolog E.M., Higgins P.G., Pearson J.D. Von Willebrand Factor is an acute phase reactant in man. Thromb Res. 53:1989;387-394.
8. Koloczko J., Wojtukiewicz M.Z., Bielawiec M., Galar M., Tarasów E. Von Willebrand factor antigen and fibronectin in essential hypertension. Thromb Res. 79:1995;331-336.
9. Margilius T., David M., Maor N., Soff G.A., Grenadier E., Palant A., Agahi E. The von Willebrand factor in myocardial infraction and unstable angina. A kinetic study Thromb Haemostas. 55:1986;366-368.
10. Albin R.J., Bartkus J.M., Gonder M.J. Immunoquantitation of factor VII-related antigen (von Willebrand factor) in prostatic cancer. Cancer Lett. 40:1988;283-289.
11. Zietek Z., Iwan-Zietek I., Paczulski R., Kotschy M., Wolski Z. Von Willebrand factor antigen in blood plasma of patients with urinary bladder carcinoma. Thromb Res. 83:1996;399-402.
12. Gadducci A., Biacchi U., Marrai R., Del-Bravo B., Fosella P.V., Facchini V. Pretreatment plasma levels of fibrinopeptide-A (FpA), D-dimer (DD), and von Willebrand factor (vWf) in patients with ovarian carcinoma. Gynecol Oncol. 53:1994;352-356.
13. Sweeney J.P., Killion K.M., Pruet C.F., Apaulding M.B. Von Willebrand factor in head and neck cancer. Cancer. 11:1990;2387-2389.
14. Coppes M.J., Zandvoort S.W.H., Sparling C.R., Poon A.O., Weitzman S., Blanchette V.S. Acquired von Willebrand disease in Wilms' tumor patients. J. Clin Oncol. 10:1992;422-427.
15. Facon T., Caron C., Courtin P., Wurtz A., Deghaye M., Bauters F., Mazurier C., Goudemand J. Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma. Br J Haem. 80:1992;488-494.
16. Karpatkin S., Pearlstein E., Amborgio C., Coller B.S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest. 81:1998;1012-1019.
17. Floyd C.M., Irani K., Kind P.D., Kessler C.M. Von Willebrand factor interacts with malignant hematopoetic cell lines. Evidence for presence of specific binding sites and modification of von Willebrand factor structure and function J Lab Clin Med. 119:1991;467-475.
18. Nierodzik M.L., Klepfish A., Karpatkin S. Role of platelet integrin GPIIb-GPIIIa, fibronectin, von Willebrand factor and thrombin in platelet-tumor interaction in vitro and metastasis in vivo. Seminars in Haematology. 31:1994;278-289.
19. Ewenstein B.M., Warchol M.J., Handin R.I., Pober J.S. Composition of the von Willebrand Factor storage organelle (Weibel-Palade Body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol. 104:1987;1423-1433.